Innovative Drug R&D In Russia Forum

Date: Oct-17-2012Adam Smith Conferences' 3rd International Innovative Drug R&D In Russia Forum will be taking place on 21 - 23 November 2012 at the Marriott Grand Hotel in Moscow.

This year the Forum's programme will present the best solutions to the most pressing problems in innovative pharma, during unique interactive sessions and discussions.

Attend this Forum to hear presentations by more than 50 high-profile speakers, including:

THE GLOBAL VIEW - INTERNATIONAL KEYNOTES: What role can Russia play in the process of developing innovations worldwide? Among our key speakers:
Salomon Azoulay, SVP, Medical & Development, Emerging Markets & Established Products, Pfizer Inc
Steve Yang, Vice President, Head of R&D, Asia and Emerging Markets, AstraZeneca
Jeroen Tonnaer, Executive Director, Business Development, Head European External Scientific Affairs, Worldwide Licensing, MSD
Michael Nohaile, Global Head, Molecular Diagnostics, Novartis Group, Switzerland
Richard Bergström, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
James Class, Director, Russia Planning and Execution, MSD-Russia
The LEADING FIGURES IN THE RUSSIAN INNOVATIVE PHARMA SECTOR will discuss how to develop an optimal life-cycle for an innovative drug, taking into account the specifics of the market and economic conditions. Speakers include:
Andrey Ivaschenko, Chairman of the Board of Directors, The ChemRar High-Tech Center
Igor Agamirzyan, General Director, Russian Venture Fund (RVC)
Sergey Tsyb, Director of the Chemical and Technological Complex and Bioengineering Technologies, Ministry of Industry and Trade of the Russian Federation
Victoria Anashkina, General Director, Amgen, Russia
Chris Janssen, Active Executive Director, Biomedicine Cluster of Skolkovo Innovation Centre
Naira Adamyan, Managing Director, Russia and CIS, Janssen Pharmaceutica
Marina Atarshchikova, Chief Scientific Officer, NOVARTIS GROUP
Andrey Petrov, Scientific Director, International Biotech Center (IBC) Generium
Roman Ivanov, Vice President, Research & Development, BIOCAD
Olga Krylova, Senior Director, Strategic Research Partnerships, External R&D Innovation, Worldwide Research & Development, Pfizer, Russia
Vitali Proutski, Head of R&D Information, AstraZeneca Russia & Head, Saint-Petersburg Predictive Science Centre
Don't miss our Special Focus Day: "Conducting Clinical Trials in Russia" on Wednesday 21 November - the only event dedicated to discussing the growth prospects for the clinical trials sector, as well as the regulatory, ethical and operational aspects of running a clinic in Russia.

Speakers include:

Ramil Abdrashitov, Clinical Research Director, AstraZeneca Russia and Ukraine;

Tatiana Serebriakova, Clinical Research Director, Russia, Ukraine, CIS, MSD;

Victoria Kosmacheva, Head of Clinical Research Department, GlaxoSmithKline;

Kirill Tverskoy, Medical Director, Pfizer, Russia;

Oleg Supryaga, Medical, Regulatory and QA Director, NYCOMED Russia-CIS, NYCOMED: a Takeda Company;

Svetlana Zavidova, Executive Director, Association of Clinical Trials Organizations (ACTO)

and many others...

For the latest information on the speaker panel and the programme, do visit the Forum website
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.